Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice

A double blind, placebo-controlled phase II study revealed that the antihistamine, Dimebon® (dimebolin, latrepirdine) improved cognition in Alzheimer disease (AD) patients compared to placebo controls. However, the Phase III CONNECTION trial failed to demonstrate significant differences between dime...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Perez, Sylvia E, Nadeem, Muhammad, Sadleir, Katherine R, Matras, Joanna, Kelley, Christy M, Counts, Scott E, Vassar, Robert, Mufson, Elliott J
Médium: Artigo
Jazyk:Inglês
Vydáno: e-Century Publishing Corporation 2012
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466490/
https://ncbi.nlm.nih.gov/pubmed/23071869
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky